Capital Fund Management S.A. Cytom X Therapeutics, Inc. Transaction History

Capital Fund Management S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$3.61 - $8.6 $66,579 - $158,609	-18,443 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$5.17 - $8.91 $19,940 - $34,365	-3,857 Reduced 17.3%	18,443 $153,000
Q3 2019 Nov 13, 2019	BUY	$7.38 - $12.25 $164,574 - $273,175	22,300 New	22,300 $165,000
Q3 2018 Nov 14, 2018	SELL	$18.04 - $26.41 $194,832 - $285,228	-10,800 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$21.38 - $29.68 $230,904 - $320,544	10,800 New	10,800 $247,000

49.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $55.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.